First Line Metastatic Breast Cancer
1 clinical trials · Condition
◉ Watch First Line Metastatic Breast Cancer
| Record | Firm | Date |
|---|---|---|
| 1st Line Treatment of Bevacizumab-Taxane vs Bevacizumab-Exemestane in Metastatic Breast Cancer (NCT01303679) | ARCAGY/ GINECO GROUP | 2010-06-01 |
Track First Line Metastatic Breast Cancer automatically
Every clearance here is in the API, with alerts when new ones post.